Selected article for: "lung disease and patient outcome"

Author: Elkan, Matan; Dvir, Ayana; Zaidenstein, Ronit; Keller, Maly; Kagansky, Dana; Hochman, Chen; Koren, Ronit
Title: Patient-Reported Outcome Measures After Hospitalization During the COVID-19 Pandemic: A Survey Among COVID-19 and Non-COVID-19 Patients
  • Cord-id: q5k94t5i
  • Document date: 2021_8_26
  • ID: q5k94t5i
    Snippet: BACKGROUND: Many people recovering from COVID-19 suffer from long-term sequelae. The objective of this study was to assess health-related quality of life (HRQoL) in COVID-19 patients several months after discharge. METHODS: We conducted a retrospective cross-sectional case–control study on COVID-19 and non-COVID-19 pneumonia patients admitted to Shamir Medical Center, Israel (03–07/2020). In the months following discharge, patients were invited to participate in a survey and fill the RAND-36
    Document: BACKGROUND: Many people recovering from COVID-19 suffer from long-term sequelae. The objective of this study was to assess health-related quality of life (HRQoL) in COVID-19 patients several months after discharge. METHODS: We conducted a retrospective cross-sectional case–control study on COVID-19 and non-COVID-19 pneumonia patients admitted to Shamir Medical Center, Israel (03–07/2020). In the months following discharge, patients were invited to participate in a survey and fill the RAND-36 questionnaire. Patients’ characteristics and comorbidities were extracted from electronic charts. RESULTS: Among 66 COVID-19 participants, the median age was 58.5 (IQR 49.8–68.3), 56.1% were female, and 36.4% were obese. The median length of stay was 7 days (IQR 4–10). Patient-reported outcome measures were reported at a median follow-up of 9-months (IQR 6–9). Pain, general health, vitality, and health change had the lowest scores (67.5, 60, 57.5, and 25, respectively). Matching to patients hospitalized with pneumonia due to other pathogens was performed on 42 of the COVID-19 patients. Non-COVID-19 patients were more frequently current or past smokers (50% vs 11.9%, p < 0.01) and suffered more often from chronic lung disease (38.1% vs 9.5%, p = 0.01). The score for health change was significantly lower in the COVID-19 group (25 vs 50, p < 0.01). CONCLUSION: Post COVID-19 patients continue to suffer from an assortment of symptoms and perceive a deterioration in their health many months after hospitalization. This emphasizes the importance of prolonged medical follow-up in this population, and the need for additional research to better understand this novel disease’s long-term effects.

    Search related documents:
    Co phrase search for related documents
    • acute follow and long recovery: 1, 2
    • acute follow and long term impact: 1, 2
    • acute illness and additional research: 1, 2, 3, 4, 5
    • acute illness and additional study: 1, 2, 3
    • acute illness and admission age: 1, 2, 3, 4, 5, 6
    • acute illness and long covid syndrome: 1, 2, 3, 4, 5, 6
    • acute illness and long hospitalization: 1, 2, 3
    • acute illness and long recovery: 1, 2, 3, 4, 5, 6, 7, 8
    • acute illness and long term burden: 1, 2
    • acute illness and long term impact: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute illness recovery and long recovery: 1, 2
    • acute infection and additional study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute infection and admission age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and admission age year: 1
    • acute infection and long covid syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and long hospitalization: 1, 2, 3, 4, 5
    • acute infection and long recovery: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute infection and long term burden: 1
    • acute infection and long term effect: 1, 2, 3